Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen, Amersham


Qiagen this week released its EasyXpress Protein Synthesis System, which produces a recombinant protein from a gene in one day. Scientists can generate expression templates using the EasyXpress Linear Template Kit, and then produce high protein yields in E coli using EasyXpress Protein Synthesis kits. Proteins with affinity tags can be recovered using Ni-NTA or Strep-Tactin matrices.

Amersham Biosciences recently launched three new products. The first, released last week, was its LabMate PD-10 Buffer Reservoir, a reservoir for its PD-10 disposable desalting columns. The reservoir allows for easier equilibration of the column.
The second product, released early this week, was its Deep Purple Protein Stain, a fluorescent stain which allows scientists to detect and quantify proteins in 1D and 2D gels more accurately and at greater quantities. According to a statement from Amersham, the stain offers up to eight times more sensitivity in protein detection and eliminates the problem of background “speckling.” The stain is compatible with Amersham’s Typhoon imager as well as other industry standard fluorescent scanners. According to Amersham, the stain is “the most sensitive in-gel fluorescent total protein stain commercially available,” and is sold for 30 percent less cost “than the other products on the market.”
The last product was ImageQuant TL software for image analysis of 1D gels, 2D gels, dot blots, slot blots, microplates, TLC, macroarray and plaque assays. ImageQuant can be used either alone or with the Amersham imager Typhoon scanner. ImageQuant was developed as part of a deal with Nonlinear Dynamics (see PM 7-25-03).

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.